previous compound ID: 1561 next compound
InChIKey: ODKSFYDXXFIFQN-BYPYZUCNSA-N
SMILES: C(C[C@@H](C(=O)O)N)CN=C(N)N

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"DY Thomas" "R Robert" "B Kus" "GW Carlile" "E Matthes" "SD Macknight" "JW Hanrahan" "J Goepp" "J Liao" "D Rotin"

chemical graph of compound 1561





CID is 6322
synonyms found at PubChem are:
L-arginine, arginine, 74-79-3, L-(+)-Arginine, L-Arg, L(+)-Arginine, H-Arg-OH, (S)-2-Amino-5-guanidinopentanoic acid, (L)-Arginine, Arginina, ARGININE, L-, L-Arginin, Arginine (VAN), Polyarginine, Argivene, Detoxargin, Levargin, Minophagen A, Argininum [INN-Latin], Arginina [INN-Spanish], L-Ornithine, N5-(aminoiminomethyl)-, Poly(L-arginine), Argamine, L-alpha-Amino-delta-guanidinovaleric acid, 1-Amino-4-guanidovaleric acid, CCRIS 3609, L-Arginine, homopolymer, NSC 206269, arg, Arginine [USAN:INN], HSDB 1429, AI3-24165, UNII-94ZLA3W45F, (S)-2-Amino-5-guanidinovaleric acid, BRN 1725413, CHEBI:16467, (S)-2-Amino-5-((aminoiminomethyl)amino)pentanoic acid, L-Norvaline, 5-((aminoiminomethyl)amino)-, (S)-(+)-arginine, EINECS 200-811-1, 2-amino-5-guanidinovaleric acid, CHEMBL1485, (2S)-2-amino-5-guanidinopentanoic acid, (S)-2-Amino-5-[(aminoiminomethyl)amino]pentanoic acid, 94ZLA3W45F, (2S)-2-amino-5-carbamimidamidopentanoic acid, Pentanoic acid, 2-amino-5-((aminoiminomethyl)amino)-, (S)-, L-a-Amino-d-guanidinovaleric acid, ODKSFYDXXFIFQN-BYPYZUCNSA-N, (2S)-2-amino-5-(carbamimidamido)pentanoic acid, L-Arginine, monohydrochloride, (2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid, Arginine HCl, Arginine (L-Arginine), (2S)-2-amino-5-guanidino-pentanoic acid, L-Norvaline, 5-[(aminoiminomethyl)amino]-, DSSTox_CID_21056, DSSTox_RID_79618, DSSTox_GSID_41056, R-gene 10, C6H14N4O2, Argininum, Pentanoic acid, 2-amino-5-[(aminoiminomethyl)amino]-, (S)-, CAS-74-79-3, Arginine [USP:INN], 2-Amino-5-Guanidnovaleric Acid, NSC203450, 3h-l-arginine, L-Arginine, labeled with tritium, 1laf, NCGC00015064-02, (S)-Arginine, L(+) arginine, L-Aryginine,(S), H-Arg, L-(+) arginine, L(+)-Arginine;, PubChem7933, L-Arginine (9CI), Arginine (USP/INN), Tocris-0663, L-Arginine (JP17), Lopac-A-5006, Arginine, L- (8CI), bmse000029, bmse000899, bmse000919, D0F5DO, D0O3VV, Epitope ID:140084, EC 200-811-1, AC1L1M9R, AC1Q4U8L, AC1Q4U8M, AC1Q4U8N, SCHEMBL1791, 2-amino-5-guanidinovalerate, Lopac0_000077, Arginine hydrochloride(USAN), GTPL721, 4-04-00-02648 (Beilstein Handbook Reference), L-a-Amino-d-guanidinovalerate, L-Amino-4-guanidovaleric acid, US9138393, L-Arginine, US9144538, L-Arginine, 1-Amino-4-guanidovalerlic acid, DTXSID6041056, BDBM21959, CTK7D2126, R-Gene 10 (Pharmacia Corp.), L-Arginine, 99%, FCC, FG, MolPort-000-000-568, MolPort-006-109-239, 26982-20-7 (hydrochloride), BDBM181132, HMS3260O15, N5-(aminoiminomethyl)-L-Ornithine, HY-N0455, ZINC1532525, L-Arginine, Vetec(TM), 98.5%, Tox21_113046, Tox21_500077, AC-083, ANW-36527, L-alpha-Amino-delta-guanidinovalerate, L-Arginine, reagent grade, >=98%, MFCD00002635, AKOS006239069, AKOS015854096, Tox21_113046_1, AM81500, CCG-204172, DB00125, LP00077, MCULE-5108123240, RP23641, RTR-032432, L-Arginine, 99%, natural, FCC, FG, (s)-2-amino-5-guanidino-pentanoic acid, 5-[(aminoiminomethyl)amino]-L-Norvaline, NCGC00015064-01, NCGC00024715-01, NCGC00024715-02, NCGC00024715-03, NCGC00024715-04, NCGC00024715-05, NCGC00260762-01, 25212-18-4, 4455-52-1, AJ-26775, AN-16154, AN-20586, AS-14190, BC204045, K277, KB-53124, LS-21576, SC-06613, L-Arginine, BioUltra, >=99.5% (NT), SBI-0207062.P001, AB0014136, AB1002666, LS-170346, LS-185750, ST2414597, TR-032432, A0526, A7079, EU-0100077, FT-0627695, L-Arginine, SAJ special grade, >=98.0%, A 5006, A50124, C00062, D02982, L-Arginine, Vetec(TM) reagent grade, >=98%, M02981, Y-8965, 14932-EP2316830A2, AB00374192_03, L-Arginine-L-Glutamate 2-Amino-Pentanedoic Acid, Norvaline, 5-[(aminoiminomethyl)amino]-, (L)-, 002A635, A837397, SR-01000075479, SR-01000597671, (S)-2-amino-5-[(aminoiminomethyl)amino]-Pentanoate, (S)-2-Amino-5-[(aminoiminomethyl)amino]pentanoate, SR-01000075479-1, SR-01000597671-1, W-104410, (S)-2-amino-5-[(aminoiminomethyl)amino]-Pentanoic acid, Arginine, European Pharmacopoeia (EP) Reference Standard, (2S)-2-amino-5-[(diaminomethylidene)amino]pentanoic acid, 7F15B0C7-356D-45D7-AC33-03AEE4394A0E, S-(+)-2-Amino-5-[(aminoiminomethyl)amino]pentanoic acid, UNII-FL26NTK3EP component ODKSFYDXXFIFQN-BYPYZUCNSA-N, (2S)-2-azanyl-5-[bis(azanyl)methylideneamino]pentanoic acid, L-Arginine, United States Pharmacopeia (USP) Reference Standard, L-Arginine, Pharmaceutical Secondary Standard; Certified Reference Material, 104352-01-4, 1332377-47-5, 142-49-4, 154605-63-7, 154605-67-1, 667422-95-9, InChI=1/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t4-/m0/s, L-, L-Arginine, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%, L-Arginine, PharmaGrade, Ajinomoto, EP, USP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture, CPSS, Protonated arginine, ARGININE, CONJUGATE MONOACID, L-, AC1L1G1Y, 17806-42-7, LS-21587, (2S)-2-amino-5-(diaminomethylideneazaniumyl)pentanoate